As global politics reshape healthcare priorities, industry leaders are calling for stronger international partnerships. At the World Economic Forum, Sino BioPharm CEO Eric Tse stressed that collaboration—not competition—is critical to solving pressing health challenges like vaccine equity and drug accessibility.
‘The Trump era taught us that isolationism doesn’t work in healthcare,’ Tse told CGTN reporter Zhu Zhu. ‘Diseases don’t care about borders. We need more bridges, whether that’s sharing research data or streamlining medical supply chains.’
Tech + Teamwork = Health Wins
Tse highlighted Sino BioPharm’s joint ventures with European biotech firms as proof that cross-border innovation works. Think mRNA tech meets traditional Chinese medicine research – a combo straight out of a sci-fi collab .
Youth Power Alert!
For Gen Z and millennials passionate about global health equity, Tse has advice: ‘Learn to code. Seriously! Digital health platforms will be tomorrow’s frontline.’ His company recently launched an AI-driven clinical trial matching app with partners in Shenzhen and Berlin.
While political tides keep shifting, Tse remains bullish: ‘Healthcare is the ultimate common language. Even rivals share a stake in curing cancer or preventing pandemics.’
Reference(s):
Sino BioPharm CEO: Cross-border healthcare collaboration essential
cgtn.com